The suppression of MMPs during cancer metastasis proves beneficial which can be done by blocking their activation or activity at transcription level via interfering with extracellular factors and signal transduction pathways (i.e., NF-kB or AP-1). This evidence concerns the gene NFKB1 and cancer.